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Abstract
Steroid	hormone	receptors	(nomenclature	as	agreed	by	the	NC-IUPHAR	Subcommittee	on
Nuclear	Hormone	Receptors	[74,	215,	3])	are	nuclear	hormone	receptors	of	the	NR3	class,	with
endogenous	agonists	that	may	be	divided	into	3-hydroxysteroids	(estrone	and	17β-estradiol)	and	3-
ketosteroids	(dihydrotestosterone	[DHT],	aldosterone,	cortisol,	corticosterone,	progesterone	and
testosterone).	For	rodent	GR	and	MR,	the	physiological	ligand	is	corticosterone	rather	than	cortisol.
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